PL2512446T3 - Kompozycja transdermalnego hydrożelu z deksibuprofenem - Google Patents
Kompozycja transdermalnego hydrożelu z deksibuprofenemInfo
- Publication number
- PL2512446T3 PL2512446T3 PL10837172T PL10837172T PL2512446T3 PL 2512446 T3 PL2512446 T3 PL 2512446T3 PL 10837172 T PL10837172 T PL 10837172T PL 10837172 T PL10837172 T PL 10837172T PL 2512446 T3 PL2512446 T3 PL 2512446T3
- Authority
- PL
- Poland
- Prior art keywords
- composition
- transdermal hydrogel
- dexibuprofen
- dexibuprofen transdermal
- hydrogel
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN3121CH2009 | 2009-12-16 | ||
| EP10837172.5A EP2512446B1 (en) | 2009-12-16 | 2010-12-09 | Composition of dexibuprofen transdermal hydrogel |
| PCT/IN2010/000795 WO2011073998A1 (en) | 2009-12-16 | 2010-12-09 | Composition of dexibuprofen transdermal hydrogel |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2512446T3 true PL2512446T3 (pl) | 2015-08-31 |
Family
ID=54200209
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL10837172T PL2512446T3 (pl) | 2009-12-16 | 2010-12-09 | Kompozycja transdermalnego hydrożelu z deksibuprofenem |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US20120259018A1 (pl) |
| EP (1) | EP2512446B1 (pl) |
| JP (1) | JP2013514347A (pl) |
| KR (1) | KR101884951B1 (pl) |
| CN (1) | CN102665681A (pl) |
| AU (1) | AU2010331761B2 (pl) |
| BR (1) | BR112012014558B8 (pl) |
| CA (1) | CA2784827C (pl) |
| DK (1) | DK2512446T3 (pl) |
| ES (1) | ES2541483T3 (pl) |
| MX (1) | MX352187B (pl) |
| PE (1) | PE20130245A1 (pl) |
| PL (1) | PL2512446T3 (pl) |
| RU (1) | RU2012129527A (pl) |
| WO (1) | WO2011073998A1 (pl) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101894891B1 (ko) * | 2012-11-30 | 2018-09-04 | 동아에스티주식회사 | 흡수가 증가된 덱시부프로펜 에멀젼 함유 겔 제형 |
| KR102210032B1 (ko) * | 2013-01-17 | 2021-02-02 | 가부시키가이샤 카나에테크노스 | 외용 첩부제 |
| CN105007750A (zh) * | 2013-02-14 | 2015-10-28 | 赛诺菲 | 用于口服给药的可咀嚼组合物及其制备方法 |
| US9855211B2 (en) * | 2013-02-28 | 2018-01-02 | Novan, Inc. | Topical compositions and methods of using the same |
| CA2920110C (en) | 2013-08-08 | 2022-05-31 | Novan, Inc. | Compositions and kits including a nitric oxide releasing compound and a hydrogel |
| EP3166593B1 (en) | 2014-07-11 | 2020-05-20 | Novan, Inc. | Topical antiviral compositions and methods of using the same |
| US10322082B2 (en) | 2014-07-11 | 2019-06-18 | Novan, Inc. | Topical antiviral compositions and methods of using the same |
| EP3177262A4 (en) | 2014-08-08 | 2018-04-18 | Novan Inc. | Topical emulsions |
| BR112017003130A2 (pt) * | 2014-08-20 | 2017-11-28 | 3M Innovative Properties Co | dispositivo e método de cultura anaeróbica autocontido para micro-organismos redutores de sulfato |
| CN104188899A (zh) * | 2014-09-26 | 2014-12-10 | 天津市聚星康华医药科技有限公司 | 一种洛索洛芬钠凝胶及其制备方法 |
| CN105168117B (zh) * | 2015-10-04 | 2018-08-07 | 临沂大学 | 一种右旋布洛芬微乳凝胶及其制备方法 |
| KR102319497B1 (ko) | 2016-03-02 | 2021-11-01 | 노반, 인크. | 염증 치료용 조성물 및 염증 치료 방법 |
| CN105935445B (zh) * | 2016-03-28 | 2019-02-01 | 赤峰赛林泰药业有限公司 | 含2-(-4-异丁基苯基)丙酸右旋物的药物组合物及其制备方法 |
| BR112018070578A2 (pt) | 2016-04-13 | 2019-02-12 | Novan, Inc. | composições, sistemas, kits, e métodos para tratar uma infecção |
| CN106074459A (zh) * | 2016-07-11 | 2016-11-09 | 雷春生 | 一种持久保水型水凝胶贴支持层材料的制备方法 |
| CN112206222A (zh) * | 2018-11-09 | 2021-01-12 | 北京德默高科医药技术有限公司 | 含有布洛芬结构类似物的多层经皮给药系统 |
| CN111388409B (zh) * | 2020-03-25 | 2023-01-31 | 牡丹江医学院 | 一种皮肤止痒抑菌贴剂用水凝胶材料的制备方法 |
| CN117545474A (zh) | 2021-11-08 | 2024-02-09 | 李维庸 | 一种用于向患者递送药物的透皮给药系统 |
| KR102419076B1 (ko) * | 2022-01-17 | 2022-07-08 | 장보경 | 마취제 조성물 및 이의 제조방법 |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8401965D0 (en) * | 1984-01-25 | 1984-02-29 | Beecham Group Plc | Composition |
| US4684666A (en) * | 1986-08-19 | 1987-08-04 | Haas Pharmaceuticals, Inc. | Stabilized liquid analgesic compositions |
| DE4024801A1 (de) * | 1990-08-04 | 1992-02-06 | Porsche Ag | Abgasanlage einer brennkraftmaschine |
| ATE195417T1 (de) * | 1991-05-13 | 2000-09-15 | Boots Co Plc | Ibuprofen-salz enthaltende pharmazeutische zusammensetzung |
| WO1995011017A1 (en) * | 1993-10-20 | 1995-04-27 | The Boots Company Plc | Ibuprofen and flurbiprofen as anti-pruritic agents |
| AT408067B (de) * | 1995-03-17 | 2001-08-27 | Gebro Pharma Gmbh | Pharmazeutische zusammensetzung zur topischen applizierung und verfahren zu ihrer herstellung |
| DK0851908T3 (da) * | 1995-06-07 | 2003-08-25 | Lee County Mosquito Control Di | Smøremiddelsammensætning og fremgangsmåde |
| US20010023261A1 (en) * | 1997-01-27 | 2001-09-20 | Lg Chemical Limited. | Novel composition for the transdermal administration of drugs |
| AU3212199A (en) * | 1998-03-31 | 1999-10-18 | Scimed Life Systems, Inc. | Temperature controlled solute delivery system |
| US6399093B1 (en) * | 1999-05-19 | 2002-06-04 | Advanced Medical Instruments | Method and composition to treat musculoskeletal disorders |
| WO2001001962A1 (en) * | 1999-07-05 | 2001-01-11 | Idea Ag. | A method for the improvement of transport across adaptable semi-permeable barriers |
| DE19945522A1 (de) * | 1999-09-23 | 2001-04-05 | Hexal Ag | Pharmazeutisches, wirkstoffhaltiges Gel |
| US20020102301A1 (en) * | 2000-01-13 | 2002-08-01 | Joseph Schwarz | Pharmaceutical solid self-emulsifying composition for sustained delivery of biologically active compounds and the process for preparation thereof |
| KR100452972B1 (ko) * | 2000-05-16 | 2004-10-14 | 주식회사 삼양사 | 경피투여용 하이드로젤 조성물 |
| US8728445B2 (en) * | 2001-05-01 | 2014-05-20 | A.V. Topchiev Institute Of Petrochemical Synthesis, Russian Academy Of Sciences | Hydrogel Compositions |
| US20030082225A1 (en) * | 2001-10-19 | 2003-05-01 | Mason Paul Arthur | Sterile, breathable patch for treating wound pain |
| PE20040321A1 (es) * | 2002-08-22 | 2004-07-15 | Novartis Consumer Health Sa | Composicion topica que comprende diclofenaco |
| US7052715B2 (en) * | 2003-04-11 | 2006-05-30 | All Natural Fmg, Inc. | Alcohol-free transdermal analgesic composition and processes for manufacture and use thereof |
| EP1633408B1 (en) * | 2003-06-19 | 2016-08-17 | Coloplast A/S | A wound care device |
| US20050025778A1 (en) * | 2003-07-02 | 2005-02-03 | Cormier Michel J.N. | Microprojection array immunization patch and method |
| CH715855B1 (de) * | 2003-08-28 | 2020-08-14 | Mibelle Ag | Zubereitung bestehend aus mindestens zwei Nanoemulsionen. |
| JP4128521B2 (ja) * | 2003-12-19 | 2008-07-30 | 信越化学工業株式会社 | ゲル状シート及びその製造方法 |
| EP1893174A2 (en) * | 2005-05-10 | 2008-03-05 | Cytophil, Inc. | Injectable hydrogels and methods of making and using same |
| JP4969812B2 (ja) * | 2005-07-22 | 2012-07-04 | 久光製薬株式会社 | ハイドロゲル組成物 |
| US20070083147A1 (en) * | 2005-09-30 | 2007-04-12 | Transcutaneous Technologies Inc. | Iontophoresis apparatus and method to deliver antibiotics to biological interfaces |
| GB0718435D0 (en) * | 2007-09-21 | 2007-10-31 | Northern Health And Social Car | Wpund care formulation |
| CN101455654B (zh) * | 2007-12-13 | 2013-03-06 | 天津医科大学 | 精氨酸布洛芬凝胶剂及其制备方法 |
| US8383614B2 (en) * | 2008-01-31 | 2013-02-26 | The Trustees Of The University Of Pennsylvania | Hypercholestrolemia and tendinous injuries |
| CA2749941C (en) * | 2008-09-10 | 2018-04-24 | Biochemics, Inc. | Ibuprofen for topical administration |
-
2010
- 2010-12-09 PL PL10837172T patent/PL2512446T3/pl unknown
- 2010-12-09 ES ES10837172.5T patent/ES2541483T3/es active Active
- 2010-12-09 PE PE2012000848A patent/PE20130245A1/es not_active Application Discontinuation
- 2010-12-09 RU RU2012129527/15A patent/RU2012129527A/ru not_active Application Discontinuation
- 2010-12-09 DK DK10837172.5T patent/DK2512446T3/en active
- 2010-12-09 EP EP10837172.5A patent/EP2512446B1/en active Active
- 2010-12-09 MX MX2012007062A patent/MX352187B/es active IP Right Grant
- 2010-12-09 AU AU2010331761A patent/AU2010331761B2/en active Active
- 2010-12-09 WO PCT/IN2010/000795 patent/WO2011073998A1/en active Application Filing
- 2010-12-09 JP JP2012543996A patent/JP2013514347A/ja active Pending
- 2010-12-09 CA CA2784827A patent/CA2784827C/en active Active
- 2010-12-09 BR BR112012014558A patent/BR112012014558B8/pt active IP Right Grant
- 2010-12-09 CN CN2010800577381A patent/CN102665681A/zh active Pending
- 2010-12-09 KR KR1020127017992A patent/KR101884951B1/ko active IP Right Grant
-
2012
- 2012-06-18 US US13/525,432 patent/US20120259018A1/en not_active Abandoned
-
2015
- 2015-08-12 US US14/824,787 patent/US10085939B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP2512446A4 (en) | 2012-10-24 |
| EP2512446A1 (en) | 2012-10-24 |
| CA2784827C (en) | 2018-10-23 |
| US10085939B2 (en) | 2018-10-02 |
| DK2512446T3 (en) | 2015-06-29 |
| RU2012129527A (ru) | 2014-01-27 |
| EP2512446B1 (en) | 2015-04-08 |
| WO2011073998A1 (en) | 2011-06-23 |
| KR101884951B1 (ko) | 2018-08-02 |
| MX352187B (es) | 2017-11-13 |
| MX2012007062A (es) | 2012-10-03 |
| CN102665681A (zh) | 2012-09-12 |
| BR112012014558B1 (pt) | 2021-02-02 |
| AU2010331761B2 (en) | 2015-09-24 |
| US20150342879A1 (en) | 2015-12-03 |
| PE20130245A1 (es) | 2013-03-08 |
| BR112012014558A2 (pt) | 2017-12-19 |
| CA2784827A1 (en) | 2011-06-23 |
| JP2013514347A (ja) | 2013-04-25 |
| BR112012014558B8 (pt) | 2021-05-25 |
| US20120259018A1 (en) | 2012-10-11 |
| BR112012014558A8 (pt) | 2018-04-10 |
| ES2541483T3 (es) | 2015-07-21 |
| KR20120092700A (ko) | 2012-08-21 |
| AU2010331761A1 (en) | 2012-07-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2512446A4 (en) | COMPOSITION OF A TRANSDERMAL DEXIBUPROFEN HYDROGEL | |
| ZA201304280B (en) | Treatment of jak2-mediated conditions | |
| EP2554175A4 (en) | COMPOSITION FOR THE TREATMENT OF A DESIRED PART | |
| EP2542515A4 (en) | PHOTOCATALYST MATERIAL COMPOSITION | |
| EP2662429A4 (en) | COMPOSITION FOR A LUBRICANT HYDROGEL AND USE THEREOF | |
| HK1178465A1 (en) | Composition for improving condition of skin | |
| HK1166280A1 (en) | Composition for treatment of tuberculosis | |
| EP2425827A4 (en) | TRANSDERMALES PREPARATION | |
| EP2654745A4 (en) | COMPOSITION FOR TREATING SKIN CONDITIONS OF THE SKIN | |
| GB0915515D0 (en) | Treatment of vasculoproliferative conditions | |
| EP2528539A4 (en) | SURFACE MODIFICATION OF IMPLANTS | |
| PL2417107T3 (pl) | Krystaliczne postacie saksagliptyny | |
| ZA201207973B (en) | Treatment of gout | |
| AP3030A (en) | Propynylaminoindan transdermal compositions | |
| EP2399607A4 (en) | TRANSDERMALE PREPARATION | |
| GB0902040D0 (en) | Composition for treatment of skin | |
| ZA201301936B (en) | Methods and compositions for treatment of diabetes and dyslipidemia | |
| EP2494966A4 (en) | STABLE COMPOSITION OF RASAGILINE | |
| IL208839A0 (en) | Structure of touch-fastening anti-skidding material | |
| PL2493496T3 (pl) | Zastosowanie GSTP1 | |
| PL2534302T3 (pl) | Kompozycja do obróbki powierzchni | |
| EP2526772A4 (en) | COMPOSITION FOR MULTIFUNCTION SURFACE TREATMENT | |
| IL222072A (en) | Composition for the treatment of primary thrombocythemia | |
| EP2654899A4 (en) | METHODS OF TREATING NEUROLOGICAL CONDITIONS AND COMPOSITIONS AND PRODUCTS USED THEREFOR | |
| GB201118532D0 (en) | Absorbent composition |